Netherlands - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Netherlands Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale fell by 13.4% year on year. At €62,791,131.78 in 2019, the country was ranked number 9 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Netherlands is overtaken by Croatia, which was ranked number 8 at €79,001,763.77 and is followed by Poland at €51,366,842.93. Denmark ranked the highest with €3,801,340,964.3 in 2019, a fall of 2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands recorded the worst performance at -13.4% per year.

Loading...

Date Euros
2019 62,791,131.78
2018 68,364,000.00
2017 90,092,000.00
2016 64,156,000.00
2015 91,230,000.00
Download all data from 1995 to 2019

How does Netherlands rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
8 #8
Croatia
79,001,763.77 2019 +0.8 % +7.0 % View data
9 #9
Netherlands
62,791,131.78 2019 -8.2 % -13.4 % View data
10 #10
Poland
51,366,842.93 2019 -7.0 % +5.1 % View data
Compare all 16 countries

Go Top